At present, we are witnessing the emergence of a scientific and technological development platform capable of offering radioisotope-based therapies and diagnostic methods new opportunities for the creation of innovative tools and, consequently, for the introduction of new production and clinical application modalities, with the profound social impact that this entails. However, the link between scientific-technological innovations and their translation into the clinical domain is not straightforward and requires a preclinical and pre-commercial context supported by strong and long-term collaborations among groups able to integrate and strengthen their respective expertise and resources.

Within this framework, the INMN 2026 workshop is based on the following key points:

• new possibilities for radioisotope production;
• nanomedicine technologies for highly selective delivery;
• understanding the impact of new high-selectivity methodologies and their heterogeneity on radiation dose distributions and the resulting radiobiological effects;
• the training of researchers and technologists capable of addressing these challenges.

Two conference days, featuring lectures and presentations, will take place on 3^rd and 5^th March at Universidad Favaloro, a meeting point for students and professionals in Medical Sciences and Biomedical Engineering, and in particular a major training center for Medical Physics professionals in Argentina. During this session, several representatives of Italian and Argentine research groups will address various topics related to the current state of research in radionuclide-based diagnostics and therapies. The possibility of remote participation will also be offered, following a schedule compatible with the Central European time zone. At the end of the workshop, dedicated time will be allocated to the discussion of the topics addressed and of potential Italian-Argentine collaborations. These discussions will be coordinated by the Department of Nanomedicine and Precision Medicine and by the Department of Boron Neutron Capture Therapy (BNCT), which has expertise in precision dosimetry.

Between the conference days, on 4^th March, there will be the possibility to attend the CUIA Institutional Day at the Istituto Italiano di Cultura di Buenos Aires. Finally, a guided visit to the laboratories of the Department of Nanomedicine and Precision Medicine of the CAC-CNEA will be organized on 6^th March. The program will include theoretical-practical presentations and laboratory visits that, taken together, constitute a precision research platform in nuclear nanomedicine at this CNEA atomic center, a reference institution for research, development, and clinical application of radiation in the healthcare sector.

Scientific committee